Atrophy, Facioscapulohumeral
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Atrophy, Facioscapulohumeral?
There are 1 clinical trial targeting Atrophy, Facioscapulohumeral tracked by BioSniper.
What is the prevalence of Atrophy, Facioscapulohumeral?
The estimated prevalence of Atrophy, Facioscapulohumeral is approximately 30.0 per 100,000 population.
Deep-dive into Atrophy, Facioscapulohumeral
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis